{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:05:16Z","timestamp":1740171916989,"version":"3.37.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"am","delay-in-days":325,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000092","name":"National Library of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.japh.2024.102258","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T20:36:10Z","timestamp":1727469370000},"page":"102258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differences in prescribing patterns of opioid dependence drugs among patients with primary alcohol use problems and opioid use disorders within New York State by social determinant factors, 2005-2018"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9647-4363","authenticated-orcid":false,"given":"Chi-Hua","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan-Yun","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zackary","family":"Falls","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Jette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0241-0753","authenticated-orcid":false,"given":"Debanjan","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter L.","family":"Elkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth E.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Bednarczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.japh.2024.102258_bib1","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/acer.13167","article-title":"Emergency department visits for adverse drug reactions involving alcohol: United States, 2005 to 2011","volume":"40","author":"Castle","year":"2016","journal-title":"Alcohol Clin Exp Res"},{"issue":"40","key":"10.1016\/j.japh.2024.102258_bib2","first-page":"881","article-title":"Alcohol involvement in opioid pain reliever and benzodiazepine drug abuse-related emergency department visits and drug-related deaths - United States, 2010","volume":"63","author":"Jones","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.japh.2024.102258_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/AJP.0b013e31816b1070","article-title":"Predicting opioid misuse by chronic pain patients: a systematic review and literature synthesis","volume":"24","author":"Turk","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.japh.2024.102258_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcrc.2016.04.022","article-title":"Opioid overdose leading to intensive care unit admission: epidemiology and outcomes","volume":"35","author":"Pfister","year":"2016","journal-title":"J\u00a0Crit Care"},{"issue":"3","key":"10.1016\/j.japh.2024.102258_bib5","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/acer.13594","article-title":"Alcohol and opioid use, co-use, and chronic pain in the context of the opioid epidemic: a critical review","volume":"42","author":"Witkiewitz","year":"2018","journal-title":"Alcohol Clin Exp Res"},{"issue":"10","key":"10.1016\/j.japh.2024.102258_bib6","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s11606-019-05068-6","article-title":"Rising prevalence of comorbid alcohol and opioid use disorders in adolescents and young adults in the United States","volume":"34","author":"Weitzman","year":"2019","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.japh.2024.102258_bib7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1749-6632.2011.06352.x","article-title":"The history of the development of buprenorphine as an addiction therapeutic","volume":"1248","author":"Campbell","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"suppl 1","key":"10.1016\/j.japh.2024.102258_bib8","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.jsat.2010.01.009","article-title":"From research to the real world: buprenorphine in the decade of the Clinical Trials Network","volume":"38","author":"Ling","year":"2010","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.japh.2024.102258_bib9","series-title":"StatPearlsPearls. Treasure Island, FL","article-title":"Naltrexone","author":"Singh","year":"2024"},{"issue":"2","key":"10.1016\/j.japh.2024.102258_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","article-title":"Prevention and treatment of opioid misuse and addiction: a review","volume":"76","author":"Volkow","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.japh.2024.102258_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108886","article-title":"An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders","volume":"226","author":"Mintz","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.japh.2024.102258_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5852","article-title":"Incidence of treatment for opioid use disorder following nonfatal overdose in commercially insured patients","volume":"3","author":"Kilaru","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.japh.2024.102258_bib13","first-page":"143","article-title":"Disparities in access to medications for opioid use disorder in the Veterans Health Administration","volume":"15","author":"Finlay","year":"2021","journal-title":"J\u00a0Addict Med"},{"key":"10.1016\/j.japh.2024.102258_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108927","article-title":"Racial inequity in medication treatment for opioid use disorder: exploring potential facilitators and barriers to use","volume":"227","author":"Hollander","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"10.1016\/j.japh.2024.102258_bib15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamapediatrics.2017.0745","article-title":"Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001\u20132014","volume":"171","author":"Hadland","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"1","key":"10.1016\/j.japh.2024.102258_bib16","first-page":"35","article-title":"Social and cultural contexts of alcohol use: influences in a social-ecological framework","volume":"38","author":"Sudhinaraset","year":"2016","journal-title":"Alcohol Res"},{"issue":"7","key":"10.1016\/j.japh.2024.102258_bib17","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1111\/j.1360-0443.2010.02931.x","article-title":"Socio-economic status predicts drinking patterns but not alcohol-related consequences independently","volume":"105","author":"Huckle","year":"2010","journal-title":"Addiction"},{"issue":"2-3","key":"10.1016\/j.japh.2024.102258_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.drugalcdep.2007.06.006","article-title":"The built environment and alcohol consumption in urban neighborhoods","volume":"91","author":"Bernstein","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2024.102258_bib19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drugalcdep.2019.03.014","article-title":"Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths","volume":"200","author":"Barocas","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.japh.2024.102258_bib20","doi-asserted-by":"crossref","first-page":"899","DOI":"10.15288\/jsad.2018.79.899","article-title":"Investigating the social ecological contexts of opioid use disorder and poisoning hospitalizations in Pennsylvania","volume":"79","author":"Mair","year":"2018","journal-title":"J\u00a0Stud Alcohol Drugs"},{"key":"10.1016\/j.japh.2024.102258_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2023.104443","article-title":"A\u00a0cohort of patients in New York State with an alcohol use disorder and subsequent treatment information-a merging of two administrative data sources","volume":"144","author":"Lu","year":"2023","journal-title":"J\u00a0Biomed Inform"},{"issue":"3","key":"10.1016\/j.japh.2024.102258_bib22","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2166\/wcc.2023.508","article-title":"Application of MK trend and test of Sen's slope estimator to measure impact of climate change on the adoption of conservation agriculture in Ethiopia","volume":"14","author":"Jiqin","year":"2023","journal-title":"J\u00a0Water Clim Change"},{"year":"1994","series-title":"Time Series Modelling of Water Resources and Environmental Systems","author":"Hipel","key":"10.1016\/j.japh.2024.102258_bib23"},{"issue":"2","key":"10.1016\/j.japh.2024.102258_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/sj.gene.6364042","article-title":"Leishmaniasis host response loci (lmr1-3) modify disease severity through a Th1\/Th2-independent pathway","volume":"5","author":"Elso","year":"2004","journal-title":"Genes Immun"},{"issue":"10","key":"10.1016\/j.japh.2024.102258_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-3024.2007.00969.x","article-title":"Wound healing response is a major contributor to the severity of cutaneous leishmaniasis in the ear model of infection","volume":"29","author":"Baldwin","year":"2007","journal-title":"Parasite Immunol"},{"issue":"1","key":"10.1016\/j.japh.2024.102258_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.32614\/RJ-2016-024","article-title":"statmod: probability calculations for the inverse Gaussian distribution","volume":"8","author":"Giner","year":"2016","journal-title":"The R Journal"},{"issue":"2","key":"10.1016\/j.japh.2024.102258_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jac5.1546","article-title":"A\u00a0large-scale, online, multiprofessional opioid prescriber training program","volume":"5","author":"Bednarczyk","year":"2022","journal-title":"J.\u00a0Am Coll Clin Pharm"},{"key":"10.1016\/j.japh.2024.102258_bib29","series-title":"Center for Behavioral Health Statistics and Quality. The CBHSQ Report","first-page":"1","article-title":"Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities 2003\u20132015 (Update)","author":"Alderks","year":"2017"},{"issue":"2","key":"10.1016\/j.japh.2024.102258_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jama.2021.7374","article-title":"Use of medications for treatment of opioid use disorder among US Medicaid enrollees in 11 states, 2014\u20132018","volume":"326","author":"Medicaid Outcomes Distributed Research Network (MODRN)","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.japh.2024.102258_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3821","article-title":"Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019","volume":"5","author":"Mauro","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.japh.2024.102258_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.12419","article-title":"Survey of barriers and facilitators to prescribing buprenorphine and clinician perceptions on the drug addiction treatment act of 2000 waiver","volume":"5","author":"Lanham","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.japh.2024.102258_bib34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.japh.2022.08.017","article-title":"Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: a national survey of community-based pharmacists","volume":"63","author":"Hill","year":"2023","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.japh.2024.102258_bib35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12913-021-06399-z","article-title":"Readmissions and costs among younger and older adults for targeted conditions during the enactment of the hospital readmission reduction program","volume":"21","author":"Lu","year":"2021","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"10.1016\/j.japh.2024.102258_bib36","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/00952990.2021.1981358","article-title":"Early buprenorphine-naloxone initiation for opioid use disorder reduces opioid overdose, emergency room visits, and healthcare cost compared to late initiation","volume":"48","author":"Sun","year":"2022","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.japh.2024.102258_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108140","article-title":"Same-day vs. delayed buprenorphine prescribing and patient retention in an office-based buprenorphine treatment program","volume":"119","author":"Jakubowski","year":"2020","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.japh.2024.102258_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107732","article-title":"Prevalence and treatment of opioid use disorders among primary care patients in six health systems","volume":"207","author":"Lapham","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2024.102258_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2016.03.028","article-title":"Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City","volume":"164","author":"Hansen","year":"2016","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.japh.2024.102258_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2105\/AJPH.2020.306000","article-title":"Increasing access to buprenorphine in safety-net primary care clinics: the New York City buprenorphine nurse care manager initiative","volume":"111","author":"Kaplan-Dobbs","year":"2021","journal-title":"Am J Public Health"},{"issue":"5","key":"10.1016\/j.japh.2024.102258_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2024.1077","article-title":"Barriers to buprenorphine dispensing by Medicaid-participating community retail pharmacies","volume":"5","author":"Freeman","year":"2024","journal-title":"JAMA Health Forum"},{"issue":"2","key":"10.1016\/j.japh.2024.102258_bib42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/29767342231215178","article-title":"Relationships between stigma, risk tolerance, and buprenorphine dispensing intentions among community-based pharmacists: results from a national sample","volume":"45","author":"Light","year":"2024","journal-title":"Subst Use Addctn J"},{"key":"10.1016\/j.japh.2024.102258_bib43","first-page":"389","article-title":"Machine learning based opioid overdose prediction using electronic health records","volume":"2019","author":"Dong","year":"2019","journal-title":"AMIA Annu Symp Proc"},{"key":"10.1016\/j.japh.2024.102258_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2021.103725","article-title":"Predicting opioid overdose risk of patients with opioid prescriptions using electronic health records based on temporal deep learning","volume":"116","author":"Dong","year":"2021","journal-title":"J\u00a0Biomed Inform"},{"issue":"8","key":"10.1016\/j.japh.2024.102258_bib45","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.sapharm.2017.12.009","article-title":"Promising roles for pharmacists in addressing the U.S. opioid crisis","volume":"15","author":"Compton","year":"2019","journal-title":"Res. Social Adm. Pharm"},{"key":"10.1016\/j.japh.2024.102258_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2022.114992","article-title":"Geographic disparities in access to Medication for Opioid Use Disorder across US census tracts based on treatment utilization behavior","volume":"302","author":"Mitchell","year":"2022","journal-title":"Soc Sci Med"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124002899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124002899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T13:16:05Z","timestamp":1739798165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319124002899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1544319124002899"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102258","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in prescribing patterns of opioid dependence drugs among patients with primary alcohol use problems and opioid use disorders within New York State by social determinant factors, 2005-2018","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102258"}}